✦ LIBER ✦

Vigabatrin therapy in six patients with succinic semialdehyde dehydrogenase deficiency

✍ Scribed by K. M. Gibson; C. Jakobs; H. Ogier; L. Hagenfeldt; K. Edebol Eeg-Olofsson; O. Eeg-Olofsson; F. Aksu; H. -P. Weber; E. Rossier; B. Vollmer; W. Lehnert

Publisher: Springer
Year: 1995
Tongue: English
Weight: 220 KB
Volume: 18
Category: Article
ISSN: 0141-8955
DOI: 10.1007/bf00711750

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vigabatrin and newer interventions in su

Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency

✍ Andrea Gropman 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Seizures in a boy with succinic semialde

Seizures in a boy with succinic semialdehyde dehydrogenase deficiency treated with vigabatrin (γ-vinyl-GABA)

✍ D. Matern; W. Lehnert; K. M. Gibson; R. Korinthenberg 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 456 KB

Monitoring of 4-hydroxybutyric acid leve

Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency

✍ Katrin Ergezinger; Reinhard Jeschke; Georg Frauendienst-Egger; Herbert Korall; K 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract We report the successful treatment using low‐dose vigabatrin (21.5–34mg/kg/day) of a 10‐year‐old girl with succinic semialdehyde dehydrogenase (SSADH) deficiency We verified that 4‐hydroxybutyric acid (GHB) concentrations in serum, cerebrospinal fluid, and urine continuously decreased i

Urinary organic acids in succinic semial

Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: Evidence of α-oxidation of 4-hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial β-oxidation

✍ G. K. Brown; C. H. Cromby; N. J. Manning; R. J. Pollitt 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 554 KB

Mutational spectrum of the succinate sem

Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency

✍ Shinjiro Akaboshi; Boris M. Hogema; Andrea Novelletto; Patrizia Malaspina; Gajja 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Succinate semialdehyde dehydrogenase (SSADH; ALDH5A1) deficiency, a rare metabolic disorder that disrupts the normal degradation of GABA, gives rise to a highly heterogeneous neurological phenotype ranging from mild to very severe. The nature of the mutation has so far been reported in patients from